Weekly paclitaxel and carboplatin followed by topotecan (TC-TP), as first-line therapy for patients with advanced epithelial ovarian cancer (AOC) suboptimally debulked. Updated preliminary results

✍ Scribed by J.A. Arranz Arija; R. Gonzalez-Beca; A. Velasco; M.M. Perez; P. Borrega; M. Bolaoos; A. Bernal; J.J. Cruz; V. Alija; P. Martinez-Prado

• Book ID: 117658819
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 363 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)81458-1